Highlights from the American Cancer Society's 41st Science Writers Seminar.
D000570:American Cancer Society; D000970:Antineoplastic Agents / Q000008:administration & dosage; D002839:Chromans / Q000008:administration & dosage; D005260:Female; D006801:Humans; D008080:Liposarcoma / Q000188:drug therapy; D008297:Male; D009369:Neoplasms / Q000175:diagnosis / Q000517:prevention & control; D017430:Prostate-Specific Antigen / Q000097:blood; D012680:Sensitivity and Specificity; D013844:Thiazoles / Q000008:administration & dosage; D045162:Thiazolidinediones; D000077288:Troglitazone; D014481:United States
D000970:Antineoplastic Agents; D002839:Chromans; D013844:Thiazoles; D045162:Thiazolidinediones; D017430:Prostate-Specific Antigen; D000077288:Troglitazone